Literature DB >> 23428618

Segmenting the etiological agent of schistosomiasis for high-content screening.

Daniel E Asarnow1, Rahul Singh.   

Abstract

Schistosomiasis is a parasitic disease with a global health impact second only to malaria. The World Health Organization has classified schistosomiasis as an illness for which new therapies are urgently needed. However, the causative parasite is refractory to current high-throughput drug screening due to the diversity and complexity of shape, appearance and movement-based phenotypes exhibited in response to putative drugs. Currently, there is no automated image-based approach capable of relieving this deficiency. We propose and validate an image segmentation algorithm designed to overcome the distinct challenges posed by schistosomes and macroparasites in general, including irregular shapes and sizes, dense groups of touching parasites and the unpredictable effects of drug exposure. Our approach combines a region-based distributing function with a novel edge detector derived from phase congruency and grayscale thinning by threshold superposition. The method is sufficiently rapid, robust and accurate to be used for quantitative analysis of diverse parasite phenotypes in high-throughput and high-content screening.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428618     DOI: 10.1109/TMI.2013.2247412

Source DB:  PubMed          Journal:  IEEE Trans Med Imaging        ISSN: 0278-0062            Impact factor:   10.048


  10 in total

1.  The QDREC web server: determining dose-response characteristics of complex macroparasites in phenotypic drug screens.

Authors:  Daniel Asarnow; Liliana Rojo-Arreola; Brian M Suzuki; Conor R Caffrey; Rahul Singh
Journal:  Bioinformatics       Date:  2014-12-24       Impact factor: 6.937

Review 2.  Modern approaches to accelerate discovery of new antischistosomal drugs.

Authors:  Bruno Junior Neves; Eugene Muratov; Renato Beilner Machado; Carolina Horta Andrade; Pedro Vitor Lemos Cravo
Journal:  Expert Opin Drug Discov       Date:  2016-05-03       Impact factor: 6.098

3.  Algorithmic Mapping and Characterization of the Drug-Induced Phenotypic-Response Space of Parasites Causing Schistosomiasis.

Authors:  Rahul Singh; Rachel Beasley; Thavy Long; Conor R Caffrey
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2016-04-07       Impact factor: 3.710

4.  Development and validation of a luminescence-based, medium-throughput assay for drug screening in Schistosoma mansoni.

Authors:  Cristiana Lalli; Alessandra Guidi; Nadia Gennari; Sergio Altamura; Alberto Bresciani; Giovina Ruberti
Journal:  PLoS Negl Trop Dis       Date:  2015-01-30

5.  Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis.

Authors:  Liliana Rojo-Arreola; Thavy Long; Dan Asarnow; Brian M Suzuki; Rahul Singh; Conor R Caffrey
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

6.  Mobile Diagnostics Based on Motion? A Close Look at Motility Patterns in the Schistosome Life Cycle.

Authors:  Ewert Linder; Sami Varjo; Cecilia Thors
Journal:  Diagnostics (Basel)       Date:  2016-06-17

7.  Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni.

Authors:  Thavy Long; R Jeffrey Neitz; Rachel Beasley; Chakrapani Kalyanaraman; Brian M Suzuki; Matthew P Jacobson; Colette Dissous; James H McKerrow; David H Drewry; William J Zuercher; Rahul Singh; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2016-01-11

8.  Natural products as leads in schistosome drug discovery.

Authors:  Bruno J Neves; Carolina H Andrade; Pedro V L Cravo
Journal:  Molecules       Date:  2015-01-23       Impact factor: 4.411

9.  Real-time and automated monitoring of antischistosomal drug activity profiles for screening of compound libraries.

Authors:  Paolo S Ravaynia; Stefan Biendl; Francesco Grassi; Jennifer Keiser; Andreas Hierlemann; Mario M Modena
Journal:  iScience       Date:  2022-03-16

Review 10.  Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.

Authors:  José T Moreira-Filho; Arthur C Silva; Rafael F Dantas; Barbara F Gomes; Lauro R Souza Neto; Jose Brandao-Neto; Raymond J Owens; Nicholas Furnham; Bruno J Neves; Floriano P Silva-Junior; Carolina H Andrade
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.